Results for tag: "Viral Conjunctivitis Drug"

Viral Conjunctivitis is an infectious disease caused by a virus, which affects the eyes and can cause redness, itching, and discharge. Treatment for this condition typically involves antiviral medications, such as topical ophthalmic drops, ointments, and oral medications. These drugs work by inhibiting the replication of the virus, reducing the severity of symptoms, and preventing further spread of the infection. The Viral Conjunctivitis Drug market is a subset of the larger Infectious Diseases Drugs market, which includes drugs used to treat a variety of infectious diseases. This market is driven by the increasing prevalence of viral conjunctivitis, as well as the development of new drugs to treat the condition. Some companies in the Viral Conjunctivitis Drug market include Allergan, Bausch + Lomb, Novartis, Pfizer, and Santen Pharmaceuticals. Show Less Read more